Stock listing
Hamburg:SQG0 Siegfried Holding AG Aktie
German listing (Hamburg) of Siegfried Holding AG · home listing SIX Swiss:SFZN
Follow Siegfried Holding AG into a list and get an email when it puts out news.
Home listing price · SIX:SFZN
65.20 CHF -2.55 (-3.8%)
Close on Nov 20, 2026 · This listing has no price on 6ix; the price shown is the home listing's, SIX:SFZN
- Day range
- 64.90 – 67.35 CHFNov 20, 2026
- Volume
- 190,518 sharesNov 20, 2026
- Market cap
- 2.86B CHFAt the close on Nov 20, 2026 · price × 43.81M shares outstanding
- 52-week range
- 64.90 – 101.60 CHFLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
- Traded on an average day
- 8.29M CHFMedian day 105,764 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026

Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| SIX Swiss:SFZN · Home | 65.20 CHF | -2.55 (-3.8%) | 190,518 | 67.15 | 67.35 | 64.90 | 67.75 | Close on Nov 20, 2026 |
| LSE:0QQO | 65.20 CHF | -2.775 (-4.1%) | 21,170 | 67.10 | 67.10 | 64.90 | 67.98 | Close on Nov 20, 2026 |
Daily closes
Last 3 months, Aug 20, 2026 – Nov 20, 2026 · SIX:SFZN · CHF, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| 65.20 | -2.55 | -3.8% | 67.15 | 67.35 | 64.90 | 190,518 | |
| 67.75 | +0.05 | +0.1% | 67.90 | 68.15 | 66.10 | 173,240 | |
| 67.70 | -2.10 | -3.0% | 69.80 | 70.15 | 67.70 | 139,003 | |
| 69.80 | -0.45 | -0.6% | 70.40 | 70.80 | 69.15 | 77,577 | |
| 70.25 | -1.00 | -1.4% | 71.40 | 71.50 | 70.00 | 90,914 | |
| 71.25 | -0.15 | -0.2% | 71.55 | 72.00 | 71.05 | 85,118 | |
| 71.40 | -0.10 | -0.1% | 71.20 | 71.85 | 70.60 | 86,368 | |
| 71.50 | +0.10 | +0.1% | 71.85 | 72.65 | 71.20 | 80,354 | |
| 71.40 | -0.60 | -0.8% | 72.00 | 72.80 | 71.35 | 95,269 | |
| 72.00 | -1.00 | -1.4% | 71.90 | 72.65 | 71.20 | 104,686 | |
| 73.00 | -1.95 | -2.6% | 75.50 | 76.40 | 73.00 | 98,658 | |
| 74.95 | +2.95 | +4.1% | 71.80 | 74.95 | 71.80 | 155,131 | |
| 72.00 | -0.55 | -0.8% | 71.85 | 72.80 | 71.70 | 69,968 | |
| 72.55 | +0.75 | +1.0% | 71.70 | 72.85 | 71.65 | 147,417 | |
| 71.80 | +1.00 | +1.4% | 71.55 | 72.20 | 71.05 | 132,614 | |
| 70.80 | -1.50 | -2.1% | 72.30 | 72.95 | 70.80 | 139,175 | |
| 72.30 | -2.75 | -3.7% | 72.70 | 73.20 | 70.65 | 101,860 | |
| 75.05 | +1.05 | +1.4% | 74.40 | 75.50 | 73.75 | 109,815 | |
| 74.00 | +0.85 | +1.2% | 73.50 | 74.40 | 72.90 | 95,003 | |
| 73.15 | +0.40 | +0.5% | 72.60 | 73.70 | 71.85 | 66,933 | |
| 72.75 | +1.15 | +1.6% | 71.50 | 73.35 | 71.30 | 91,767 | |
| 71.60 | +0.05 | +0.1% | 71.50 | 72.15 | 71.00 | 84,344 | |
| 71.55 | +0.40 | +0.6% | 71.40 | 72.40 | 70.90 | 74,087 | |
| 71.15 | +1.00 | +1.4% | 70.00 | 71.15 | 69.95 | 59,147 | |
| 70.15 | +0.15 | +0.2% | 70.20 | 70.60 | 69.65 | 96,252 | |
| 70.00 | +0.40 | +0.6% | 69.90 | 70.70 | 69.55 | 113,465 | |
| 69.60 | +1.25 | +1.8% | 69.15 | 70.55 | 69.15 | 110,768 | |
| 68.35 | +0.25 | +0.4% | 68.10 | 68.70 | 67.60 | 105,265 | |
| 68.10 | +0.60 | +0.9% | 67.50 | 68.10 | 66.10 | 80,654 | |
| 67.50 | -0.10 | -0.1% | 68.20 | 68.70 | 67.50 | 69,439 | |
| 67.60 | -1.35 | -2.0% | 68.30 | 68.80 | 67.55 | 102,650 | |
| 68.95 | -1.40 | -2.0% | 69.85 | 70.55 | 68.25 | 108,419 | |
| 70.35 | +0.95 | +1.4% | 69.95 | 73.10 | 69.95 | 170,225 | |
| 69.40 | -0.40 | -0.6% | 70.25 | 70.80 | 68.95 | 106,283 | |
| 69.80 | -0.80 | -1.1% | 70.05 | 71.20 | 69.65 | 85,824 | |
| 70.60 | -1.40 | -1.9% | 71.20 | 71.30 | 69.90 | 111,216 | |
| 72.00 | -0.45 | -0.6% | 72.60 | 73.50 | 72.00 | 116,815 | |
| 72.45 | -1.00 | -1.4% | 73.70 | 74.55 | 72.35 | 107,695 | |
| 73.45 | +0.85 | +1.2% | 73.00 | 74.00 | 73.00 | 73,054 | |
| 72.60 | -1.55 | -2.1% | 74.45 | 74.60 | 71.10 | 119,222 | |
| 74.15 | -0.25 | -0.3% | 74.00 | 74.85 | 73.55 | 82,614 | |
| 74.40 | +0.10 | +0.1% | 74.25 | 75.20 | 73.90 | 74,496 | |
| 74.30 | +1.70 | +2.3% | 72.70 | 74.30 | 71.95 | 66,338 | |
| 72.60 | -0.55 | -0.8% | 73.40 | 73.85 | 72.55 | 101,866 | |
| 73.15 | -1.05 | -1.4% | 73.85 | 75.35 | 73.00 | 198,976 | |
| 74.20 | +1.50 | +2.1% | 72.85 | 74.25 | 72.15 | 96,406 | |
| 72.70 | -0.55 | -0.8% | 73.50 | 74.35 | 72.25 | 127,554 | |
| 73.25 | +0.10 | +0.1% | 72.75 | 73.65 | 72.65 | 82,971 | |
| 73.15 | +2.50 | +3.5% | 71.85 | 73.90 | 71.85 | 128,495 | |
| 70.65 | -0.20 | -0.3% | 70.75 | 71.85 | 70.50 | 72,694 | |
| 70.85 | -0.20 | -0.3% | 71.50 | 71.50 | 70.50 | 119,421 | |
| 71.05 | -0.25 | -0.4% | 70.40 | 71.05 | 69.65 | 96,231 | |
| 71.30 | +1.75 | +2.5% | 69.50 | 71.90 | 69.40 | 112,632 | |
| 69.55 | -0.95 | -1.3% | 70.35 | 70.65 | 69.55 | 70,411 | |
| 70.50 | -0.25 | -0.4% | 70.70 | 70.95 | 70.05 | 110,151 | |
| 70.75 | -2.60 | -3.5% | 73.10 | 73.65 | 70.75 | 229,762 | |
| 73.35 | +2.35 | +3.3% | 71.30 | 73.60 | 71.00 | 207,211 | |
| 71.00 | -1.40 | -1.9% | 72.50 | 73.30 | 70.75 | 124,372 | |
| 72.40 | -1.75 | -2.4% | 73.90 | 73.95 | 72.40 | 143,731 | |
| 74.15 | +0.30 | +0.4% | 73.50 | 74.40 | 73.50 | 157,656 | |
| 73.85 | -0.05 | -0.1% | 74.10 | 74.40 | 73.45 | 104,079 | |
| 73.90 | -0.55 | -0.7% | 74.35 | 74.65 | 73.50 | 106,262 | |
| 74.45 | -1.40 | -1.8% | 76.20 | 76.25 | 74.20 | 116,577 | |
| 75.85 | -4.40 | -5.5% | 78.35 | 78.65 | 73.60 | 297,214 | |
| 80.25 | +2.10 | +2.7% | 82.15 | 85.40 | 79.60 | 231,231 | |
| 78.15 | -0.40 | -0.5% | 78.65 | 79.60 | 77.95 | 110,142 |
Splits
2 splits since 2002 · SIX:SFZN · every price before a split is adjusted for it
| Day | Ratio | What |
|---|---|---|
| 10-for-1 | Split | |
| 10-for-1 | Split |
- Ticker
- Hamburg:SQG0
- Asset type
- Stock
- Sector
- Health care
- Industry
- Diagnostics & research services
- Exchange
- Hamburg
- Currency
- EUR
What changed lately
Latest news release · Aug 21, 2026
Siegfried delivers profitable growth and confirms outlook
Latest earnings call · Aug 21, 2026
Siegfried Holding (SIX Swiss: SFZN) Q2 2026 Earnings Call
Replay and transcript
Latest deck · Aug 21, 2026
H1 2026 Earnings Presentation
Earnings · 19 slides
Latest news
Siegfried delivers profitable growth and confirms outlook
Aug 21, 2026
Closed 80.25 (+2.7%) on Aug 21, 2026
Change in Siegfried’s management team
Jul 16, 2026
Closed 73.05 (-1.4%) on Jul 16, 2026
Change in Siegfried's management team
Jul 16, 2026
Closed 73.05 (-1.4%) on Jul 16, 2026
Siegfried strengthens manufacturing network with new large-scale drug substance facility in Minden
Jun 16, 2026
Closed 66.90 (-7.6%) on Jun 16, 2026
Siegfried successfully places senior bonds of CHF 200 million
May 26, 2026
Closed 82.00 (+2.2%) on May 26, 2026
Siegfried included in Dow Jones Best-in-Class Europe Index
May 7, 2026
Closed 83.35 (+1.0%) on May 7, 2026
SK Capital Partners Completes Sale of Noramco, Extractas Biosciences, and Purisys to Siegfried Holding AG
May 1, 2026
Closed 79.85 (+1.5%) on May 4, 2026
Siegfried DINAMIQS receives Swissmedic license for viral vector manufacturing
Apr 29, 2026
Closed 77.55 (+1.0%) on Apr 29, 2026
Siegfried obtains antitrust clearance for acquisition of three drug substances sites in the US and Australia
Apr 24, 2026
Closed 78.05 (-1.4%) on Apr 24, 2026
Siegfried shareholders approve all proposals at Annual General Meeting 2026
Apr 16, 2026
Closed 82.10 (-1.7%) on Apr 16, 2026
Siegfried Holding AG on 6ix
- Sector
- Health care
- Industry
- Diagnostics & research services
- News releases
- 18 in the last 12 months · 21 in all · newest Aug 21, 2026 · oldest 2025
- Calls
- 1 call with a replay · 1 with a transcript · latest Aug 21, 2026
- Decks
- 25 decks · latest Aug 21, 2026
Where Siegfried Holding AG is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| SIX Swiss:SFZN · Home listing | SIX Swiss | Switzerland | CHF |
| LSE:0QQO | LSE | United Kingdom | CHF |
| gettex:SQG0 | gettex | Germany | EUR |
| BX Swiss:SFZN | BX Swiss | Switzerland | CHF |
| Lang & Schwarz:A41BKT | Lang & Schwarz | Germany | EUR |
| LS Exchange:A41BKT | LS Exchange | Germany | EUR |
| Tradegate:SQG0 | Tradegate | Germany | EUR |
| Aquis:SFZNZ | Aquis | United Kingdom | CHF |
| OTC:SGFEF | OTC | United States | USD |
| VIE:SFZN | Vienna | Austria | EUR |
| Turquoise:SFZNZ | Turquoise | United Kingdom | CHF |
| Dusseldorf:SQG0 | Dusseldorf | Germany | EUR |
| Frankfurt:SQG0 | Frankfurt | Germany | EUR |
| Hamburg:SQG0 · This page | Hamburg | Germany | EUR |
| Munich:SQG0 | Munich | Germany | EUR |
| Stuttgart:SQG0 | Stuttgart | Germany | EUR |
Valuation
P/E 16.9× against a median of 28.6×: the lowest of 8 Diagnostics & research services companies shown. Statements: Year to Dec 31, 2025 · balance Jun 30, 2026 · price Nov 20, 2026
- Enterprise value
- 3.68B CHF
- P/E
- 16.9×
- EV/sales
- 2.8×
- EV/EBITDA
- 12.0×
- Price/book
- 2.9×
- Gross margin
- 26.5%
- Operating margin
- 15.8%
- Net margin
- 12.7%
- Debt to equity
- 0.9×
- Beta
- No index for this market yet
Diagnostics & research services: the 10 companies nearest in size, of 302 on 6ix with figures. Size in US dollars.
| Company | Mkt cap | EV | P/E | EV/Sales | EV/EBITDA | P/B | Net mgn | Debt/Eq | Beta |
|---|---|---|---|---|---|---|---|---|---|
| Siegfried Holding AG · SIX:SFZN | US$3.40B | US$4.38B | 16.9× | 2.8× | 12.0× | 2.9× | 12.7% | 0.9× | n/a |
| SAI Life Sciences Ltd. · NSE:SAILIFE | US$4.13B | US$4.13B | 106× | 17.0× | 58.1× | 15.4× | 16.1% | 0.0× | n/a |
| BillionToOne, Inc. · NASDAQ:BLLN | US$3.83B | US$3.36B | 77.6× | 7.7× | 59.6× | 6.8× | 11.3% | 0.2× | 1.35 |
| CareDx, Inc. · NASDAQ:CDNA | US$3.68B | US$3.43B | 28.6× | 6.9× | n/a | 7.9× | 25.9% | 0.0× | 1.26 |
| Tecan Group AG · SIX:TECN | US$3.50B | US$3.49B | n/a | 3.3× | 34.0× | 2.6× | −12.5% | 0.2× | n/a |
| Piramal Pharma Limited · NSE:PPLPHARMA | US$3.42B | US$3.97B | n/a | 3.8× | 30.6× | 3.9× | −2.1% | 0.7× | n/a |
| Apeloa Pharmaceutical Co. Ltd. Class A · SZSE:000739 | US$3.30B | US$2.85B | 27.3× | 2.1× | n/a | 3.4× | 9.1% | 0.1× | n/a |
| Autobio Diagnostics Co., Ltd. Class A · SSE:603658 | US$3.29B | US$3.06B | 20.8× | 4.7× | n/a | 2.4× | 24.3% | 0.0× | n/a |
| Joinn Laboratories (China) Co., Ltd. Class A · SSE:603127 | US$3.05B | US$2.67B | 17.7× | 9.6× | n/a | 2.2× | 61.6% | 0.0× | n/a |
| MGI Tech Co., Ltd. Class A · SSE:688114 | US$2.92B | US$2.54B | n/a | 5.5× | n/a | 2.8× | −9.5% | 0.2× | n/a |
| Neuland Laboratories Ltd. · NSE:NEULANDLAB | US$2.86B | US$2.80B | 58.5× | 11.3× | 36.8× | 13.1× | 19.6% | 0.2× | n/a |
| Median of the others | US$3.36B | US$3.21B | 28.6× | 6.2× | 36.8× | 3.7× | 13.7% | 0.1× | 1.31 |
Forecasts
Analysts' consensus from EODHD, read Nov 20, 2026. Not 6ix's view and not investment advice.
- Price target
- 98.92 CHF · Analysts' mean
- EPS, year to Dec 2026
- 4.10 · 9 analysts
- Revenue, year to Dec 2026
- 1.42B · 11 analysts
Team and board
Officers
| Officer | Role |
|---|---|
| Marcel Imwinkelried | Chief Executive Officer and COO Drug Products ad interim |
| Tania Micki | Chief Financial Officer |
| Eduardo Montanha | Chief Operating Officer |
| Peter Stierli | Head Corporate Communications |
| Olesia Silanteva | Chief Human Resources Officer |
| Peter Freisler | Chief Business Officer |
| Stefan Randl | Chief Scientific Officer |
Board
| Director | Role |
|---|---|
| Andreas Casutt | Chairman of the Board of Directors |
| Beat Walti | Chairman of the Board of Directors |
| Alexandra Brand | Board Member |
| Elodie Carr-Cingari | Board Member |
| Isabelle Welton | Board Member |
| Karl Petersson | Member of the Board of Directors |
| Martin Schmid | Vice Chair |
| Thomas Wozniewski | Member of the Board of Directors |
| Wolfram Carius | Board Member |
Events
- Next results
- Feb 23, 2027 (expected)
Calls
| Call | When | Status |
|---|---|---|
| Siegfried Holding (SIX Swiss: SFZN) Q2 2026 Earnings Call | Fri, Aug 21, 2026 · 4:00 AM ET | Replay |
Results days
| Quarter | Results | Share move |
|---|---|---|
| Q4 2025 | Dec 31, 2025 | +0.1% |
| Q2 2025 | Aug 21, 2025 · After close | +1.6% |
| Q4 2024 | Feb 18, 2025 | −7.6% |
| Quarter to Sep 30, 2024 | Nov 18, 2024 | +3.0% |
| Q2 2024 | Aug 22, 2024 | +10.4% |
| Quarter to Mar 31, 2024 | May 29, 2024 | +0.1% |
| Q4 2023 | Feb 20, 2024 | −5.7% |
| Quarter to Sep 30, 2023 | Oct 27, 2023 | +5.4% |
| Q2 2023 | Aug 17, 2023 · Before open | +5.4% |
| Q1 2023 | May 31, 2023 | +2.4% |
All 19 quarters
| Quarter | Results | Share move |
|---|---|---|
| Q4 2022 | Feb 22, 2023 · After close | +1.3% |
| Q3 2022 | Oct 28, 2022 | −0.3% |
| Q2 2022 | Aug 18, 2022 · Before open | +15.7% |
| Q1 2022 | Jun 1, 2022 | −1.3% |
| Q4 2021 | Feb 23, 2022 · Before open | +0.8% |
| Q3 2021 | Oct 29, 2021 | +1.8% |
| Q2 2021 | Sep 16, 2021 | −2.0% |
| Q1 2021 | Jun 2, 2021 | −1.6% |
| Q4 2020 | Feb 24, 2021 | +8.2% |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| H1 2026 Earnings Presentation | Earnings | 19 slides | Aug 21, 2026 |
| FY2025 Earnings Presentation | Earnings | 26 slides | Feb 20, 2026 |
| Merger or Acquisition (January 2026) | Merger or acquisition | 9 slides | Jan 27, 2026 |
| H1 2025 Earnings Presentation | Earnings | 18 slides | Aug 21, 2025 |
| FY2024 Earnings Presentation | Earnings | 29 slides | Feb 18, 2025 |
| Investor Day (October 2024) | Investor day | 62 slides | Oct 24, 2024 |
| H1 2024 Earnings Presentation | Earnings | 20 slides | Aug 22, 2024 |
| Merger or Acquisition (June 2024) | Merger or acquisition | 10 slides | Jun 12, 2024 |
| Investor Presentation (March 2024) | Investor deck | 26 slides | March 2024 |
| FY2023 Earnings Presentation | Earnings | 24 slides | Feb 20, 2024 |
All 25 decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Investor Presentation (September 2023) | Investor deck | 27 slides | September 2023 |
| H1 2023 Earnings Presentation | Earnings | 19 slides | Aug 17, 2023 |
| FY2022 Earnings Presentation | Earnings | 24 slides | Feb 22, 2023 |
| H1 2022 Earnings Presentation | Earnings | 20 slides | Aug 18, 2022 |
| FY2021 Earnings Presentation | Earnings | 25 slides | Feb 23, 2022 |
| H1 2021 Earnings Presentation | Earnings | 23 slides | Aug 19, 2021 |
| FY2020 Earnings Presentation | Earnings | 32 slides | Feb 24, 2021 |
| Fact Sheet (October 2020) | Fact sheet | 4 slides | October 2020 |
| FY2019 Earnings Presentation | Earnings | 32 slides | Mar 4, 2020 |
| FY2018 Earnings Presentation | Earnings | 30 slides | Mar 7, 2019 |
| FY2017 Earnings Presentation | Earnings | 25 slides | Mar 14, 2018 |
| FY2016 Earnings Presentation | Earnings | 18 slides | Mar 14, 2017 |
| H1 2015 Earnings Presentation | Earnings | 25 slides | Aug 19, 2015 |
| Merger or Acquisition (May 2015) | Merger or acquisition | 18 slides | May 7, 2015 |
| Fact Sheet (2014) | Fact sheet | 4 slides | 2014 |
Financings
| Raise | Date | In US dollars |
|---|---|---|
| Senior bonds Announced: CHF 300M · Zürcher Kantonalbank +1 Dealers: Zürcher Kantonalbank (co-lead), Commerzbank (co-lead) Use of proceeds: General corporate purposes, including early refinancing of the bonds maturing in June 2026 | Sep 11, 2025 | US$376.71M |
Open Financings · Read by 6ix AI from the company's releases
Financials
Annual, in CHF
Income statement
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1.33B | 1.29B | 1.27B | 1.23B | 1.10B | 845.1M | 833.5M | 794.3M | 750.5M | 717.7M |
| Cost of revenue | 975.4M | 965.5M | 951.1M | 910.8M | 863.2M | 669.1M | 661.0M | 637.8M | 611.7M | 608.5M |
| Gross profit | 352.4M | 329.1M | 320.4M | 318.7M | 239.3M | 176.0M | 172.5M | 156.5M | 138.8M | 109.2M |
| Research and development | 46.2M | 41.1M | 44.5M | 43.2M | 40.7M | 31.2M | 33.3M | 27.5M | 25.6M | 21.2M |
| Selling, general and administrative | 80.1M | 80.3M | 89.5M | 31.1M | 54.7M | 51.6M | 70.2M | 41.8M | 41.3M | 31.5M |
| Operating income | 210.3M | 199.3M | 172.1M | 227.6M | 130.0M | 77.4M | 54.9M | 77.6M | 61.8M | 40.1M |
| Depreciation and amortization | 96.4M | 84.7M | 81.4M | 81.7M | 82.8M | 55.1M | 51.6M | 49.6M | 49.4M | 50.0M |
| EBITDA | 306.7M | 284.0M | 253.4M | 309.4M | 212.8M | 132.5M | 106.4M | 127.2M | 111.2M | 90.2M |
| Interest expense | 7.14M | 8.53M | 9.29M | 7.57M | 3.86M | 2.85M | 3.15M | 3.66M | 3.69M | 7.80M |
| Income before tax | 208.7M | 196.3M | 150.4M | 218.8M | 126.6M | 74.1M | 51.5M | 70.2M | 57.9M | 34.7M |
| Income tax | 40.3M | 36.4M | 37.7M | 62.3M | 30.9M | 13.2M | -1.71M | 13.9M | 17.0M | 6.83M |
| Net income | 168.7M | 160.1M | 112.8M | 156.5M | 95.6M | 60.9M | 53.1M | 56.3M | 39.7M | 27.9M |
| Earnings per share, basic | 3.85 | 3.69 | 26.22 | 3.63 | 2.20 | 1.42 | 1.25 | 13.10 | 9.71 | 7.04 |
Balance sheet
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 103.1M | 38.8M | 56.4M | 91.5M | 72.6M | 54.4M | 25.4M | 39.9M | 34.1M | 31.6M |
| Short-term investments | 713.0K | 856.0K | 263.0K | 135.0K | 345.0K | 30.0K | 30.0K | 30.0K | 30.0K | 471.0K |
| Receivables | 504.3M | 411.4M | 484.3M | 423.1M | 363.7M | 261.1M | 250.8M | 217.0M | 189.2M | 155.8M |
| Inventory | 409.5M | 387.6M | 431.9M | 405.8M | 364.7M | 272.4M | 257.0M | 227.5M | 248.3M | 243.7M |
| Current assets | 1.05B | 939.4M | 983.2M | 944.9M | 826.2M | 651.0M | 590.0M | 533.9M | 513.5M | 468.1M |
| Property, plant and equipment | 1.02B | 910.0M | 801.1M | 779.9M | 789.3M | 534.6M | 518.4M | 520.6M | 500.2M | 489.3M |
| Total assets | 2.15B | 1.93B | 1.86B | 1.79B | 1.67B | 1.24B | 1.17B | 1.10B | 1.07B | 1.02B |
| Accounts payable | 110.4M | 95.5M | 98.8M | 114.1M | 119.9M | 69.0M | 78.9M | 69.3M | 71.3M | 55.3M |
| Current liabilities | 524.7M | 306.6M | 397.8M | 317.6M | 270.8M | 193.6M | 301.5M | 151.3M | 147.7M | 123.6M |
| Long-term debt | 375.2M | 490.1M | 445.0M | 482.1M | 480.0M | 140.0M | 0 | 110.0M | 100.0M | 91.1M |
| Total debt | 575.2M | 490.1M | 525.0M | 590.0M | 560.0M | 377.5M | 391.0M | 366.0M | 356.0M | 407.1M |
| Total liabilities | 1.03B | 953.8M | 1.02B | 1.08B | 1.06B | 746.6M | 733.0M | 424.3M | 403.2M | 360.6M |
| Shareholders' equity | 1.13B | 980.2M | 838.2M | 710.9M | 608.2M | 495.7M | 435.7M | 678.8M | 667.8M | 660.7M |
| Shares outstanding | 43.8M | 43.4M | 4.30M | 43.1M | 43.4M | 42.9M | 42.4M | 4.30M | 4.09M | 3.97M |
Cash flow
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | 221.9M | 168.8M | 208.6M | 142.3M | 119.7M | 114.8M | 65.6M | 106.0M | 84.6M | 57.1M |
| Capital spending | -211.9M | -180.8M | -137.1M | -115.2M | -113.4M | -69.1M | -61.9M | -58.8M | -51.9M | -64.9M |
| Free cash flow | 9.97M | -12.1M | 71.5M | 27.1M | 6.35M | 45.6M | 3.74M | 47.2M | 32.7M | -7.80M |
| Cash from investing | -231.3M | -190.3M | -146.9M | -103.7M | -250.0M | -68.7M | -61.8M | -61.8M | -52.2M | -65.8M |
| Cash from financing | 74.8M | 3.04M | -94.8M | -18.6M | 148.8M | -15.9M | -17.8M | -37.9M | -30.0M | -5.35M |
| Dividends paid | -16.6M | -15.4M | -14.4M | -13.5M | -12.6M | -11.6M | -10.8M | -9.96M | -7.83M | -7.00M |
| Share buybacks | 1.34M | -18.7M | -6.48M | -24.1M | -12.7M | -3.85M | -22.9M | -29.4M | -19.9M | -13.2M |
| Change in cash | 64.3M | -17.6M | -35.1M | 18.9M | 18.2M | 29.0M | -14.4M | 5.74M | 2.50M | -15.8M |
Cap table
Built by 6ix from Siegfried Holding AG’s releases · as of Sep 11, 2025
- Common shares
- 43,808,440
- Fully diluted
- 43,808,440
Fully diluted
| Line | Shares |
|---|---|
| Common shares | 43,808,440 |
Share count over time
| Count | Shares |
|---|---|
| Nov 22, 2026 | 43,808,440 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Reto Suter Other companies: Leonteq AG (Member of the Board of Directors · Since at least Aug 25, 2026); INFICON Holding AG (Director, Member of the Compensation and Human Resources Committee, Chairman of the Audit Committee · Since at least Apr 22, 2026) | Jun 16, 2026 – Aug 21, 2026 · Past |
| Andreas Casutt Other companies: Leonteq AG (Member of the Board of Directors · Since at least Aug 25, 2026) | Chairman of the Board of Directors · Since at least Apr 16, 2026 |
| Alexandra Brand | Board Member · Since at least Apr 16, 2026 |
| Beat Walti | Chairman of the Board of Directors · Since at least Apr 16, 2026 |
| Eduardo Montanha | Chief Operating Officer · Since at least Jul 16, 2026 |
| Elodie Carr-Cingari | Board Member · Since at least Apr 16, 2026 |
| Isabelle Welton | Board Member · Since at least Apr 16, 2026 |
| Karl Petersson | Member of the Board of Directors · Since at least Apr 16, 2026 |
| Marcel Imwinkelried | Chief Executive Officer and COO Drug Products ad interim · Since at least Aug 21, 2026 |
| Martin Schmid | Vice Chair · Since at least Apr 16, 2026 |
All 17 people
| Person | Seat |
|---|---|
| Olesia Silanteva | Chief Human Resources Officer · Since at least Nov 5, 2026 |
| Peter Freisler | Chief Business Officer · Since at least Nov 5, 2026 |
| Peter Stierli | Head Corporate Communications · Since at least Aug 21, 2026 |
| Stefan Randl | Chief Scientific Officer · Since at least Feb 20, 2026 |
| Tania Micki | Chief Financial Officer · Since at least Aug 21, 2026 |
| Thomas Wozniewski | Member of the Board of Directors · Since at least Apr 16, 2026 |
| Wolfram Carius | Board Member · Since at least Apr 16, 2026 |
Log in to ask 6ix AI your own questions about Siegfried Holding AG.